Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2022 Filed Mar 29, 2022 23:14 UTC |
Kim DongChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.61 | $0.00 |
DisclosureSEC source: 0001209191-22-021524 · doc4.xml · derivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2032-03-24 F1 · derivative.exercise_date: One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025. Read SEC document |
| March 25, 2022 Filed Feb 12, 2024 22:43 UTC Amendment |
Kim DongChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.61 | $0.00 |
DisclosureSEC source: 0001437749-24-003792 · rdgdoc.xml · derivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2032-03-25 F2 · shares: This amendment corrects and restates the number of derivative securities acquired reported in the original Form 4 filed on March 29, 2022. F1 · derivative.exercise_date: One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025. F3 · derivative.expiration_date: This amendment corrects and restates the expiration date reported in the original Form 4 filed on March 29, 2022. F4 · derivative.underlying_shares: This amendment corrects and restates the amount of securities underlying derivative security reported in the original Form 4 filed on March 29, 2022. F5 · balance_after: This amendment corrects and restates the number of derivative securities beneficially owned following reported transaction reported in the original Form 4 filed on March 29, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · derivative · entry 8 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F6 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F6 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · derivative · entry 7 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Ordinary Shares · 0 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F5 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025 F5 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025 Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 12,064 | $0.00 Strike: $7.72 | $0.00 |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · derivative · entry 6 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,064 Underlying: Ordinary Shares · 12,064 shares Expires 2032-01-31 F4 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025 Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · derivative · entry 5 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,099 | $7.58 | $8,330.42 |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · nonDerivative · entry 4 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,221 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 275 | $7.58 | $2,084.50 |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,320 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:33 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-006384 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:35 UTC |
Smith Jason DrewGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.72 | $0.00 |
DisclosureSEC source: 0001209191-22-006387 · doc4.xml · derivative · entry 5 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2032-01-31 F5 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:35 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006387 · doc4.xml · derivative · entry 4 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F4 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025. F4 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:35 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006387 · doc4.xml · derivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,667 Underlying: Ordinary Shares · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:35 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 414 | $7.58 | $3,138.12 |
DisclosureSEC source: 0001209191-22-006387 · doc4.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,449 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:35 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-006387 · doc4.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:34 UTC |
Henderson MollyChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $7.72 | $0.00 |
DisclosureSEC source: 0001209191-22-006385 · doc4.xml · derivative · entry 5 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2032-01-31 F5 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:34 UTC |
Henderson MollyChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006385 · doc4.xml · derivative · entry 4 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F4 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025. F4 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:34 UTC |
Henderson MollyChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006385 · doc4.xml · derivative · entry 3 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,334 Underlying: Ordinary Shares · 1,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 2,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 2,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:34 UTC |
Henderson MollyChief Financial Officer
|
SaleOrdinary Shares | 331 | $7.58 | $2,508.98 |
DisclosureSEC source: 0001209191-22-006385 · doc4.xml · nonDerivative · entry 2 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,248 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:34 UTC |
Henderson MollyChief Financial Officer
|
Exercise / conversionOrdinary Shares | 666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-006385 · doc4.xml · nonDerivative · entry 1 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $7.72 | $0.00 |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · derivative · entry 7 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Ordinary Shares · 150,000 shares Expires 2032-01-31 F5 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025 Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · derivative · entry 6 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,667 Underlying: Ordinary Shares · 13,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F4 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022. F4 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · derivative · entry 5 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
SaleOrdinary Shares | 5,960 | $7.58 | $45,176.80 |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · nonDerivative · entry 4 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,358 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 13,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · nonDerivative · entry 3 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
SaleOrdinary Shares | 2,235 | $7.58 | $16,941.30 |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · nonDerivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,985 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:32 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-006383 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:29 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005416 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:29 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 111 | $8.09 | $897.99 |
DisclosureSEC source: 0001209191-22-005416 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,095 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:29 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-005416 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 13:38 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
SaleOrdinary Shares | 46,968 | $9.15 | $429,757.20 |
DisclosureSEC source: 0001209191-22-002305 · doc4.xml · nonDerivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,220 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| January 03, 2022 Filed Jan 7, 2022 13:38 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 105,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002305 · doc4.xml · derivative · entry 3 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 105,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs vested on January 3, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs vested on January 3, 2022. Read SEC document |
| January 03, 2022 Filed Jan 7, 2022 13:38 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 105,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-002305 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:16 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-067440 · doc4.xml · derivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Ordinary Shares · 8,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of November 30, 2021, August 31, 2022 and August 31, 2023. F3 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of November 30, 2021, August 31, 2022 and August 31, 2023. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:16 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,803 | $12.03 | $45,750.09 |
DisclosureSEC source: 0001209191-21-067440 · doc4.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,030 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:16 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 8,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-067440 · doc4.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:15 UTC |
Henderson MollyChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-067439 · doc4.xml · derivative · entry 3 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of November 30, 2021, October 1, 2022 and October 1, 2023. F3 · derivative.expiration_date: 1/3 of the shares underlying the stock options will vest on each of November 30, 2021, October 1, 2022 and October 1, 2023. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:15 UTC |
Henderson MollyChief Financial Officer
|
SaleOrdinary Shares | 2,587 | $12.03 | $31,121.61 |
DisclosureSEC source: 0001209191-21-067439 · doc4.xml · nonDerivative · entry 2 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:15 UTC |
Henderson MollyChief Financial Officer
|
Exercise / conversionOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-067439 · doc4.xml · nonDerivative · entry 1 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 20:05 UTC |
Schoenberg MarkChief Medical Officer
|
PurchaseOrdinary Shares | 160 | $13.10 | $2,096.00 |
DisclosureSEC source: 0001209191-21-065756 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,997 Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 19:45 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 258 | $17.16 | $4,427.28 |
DisclosureSEC source: 0001209191-21-062360 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,837 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 19:45 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062360 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 19:45 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-062360 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 18:04 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 107 | $16.32 | $1,746.24 |
DisclosureSEC source: 0001209191-21-061868 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,595 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 18:04 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-061868 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 Underlying: Ordinary Shares · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 18:04 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-061868 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 23:07 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 243 | $15.64 | $3,800.52 |
DisclosureSEC source: 0001209191-21-049477 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,494 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| July 31, 2021 Filed Aug 3, 2021 23:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049477 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| July 31, 2021 Filed Aug 3, 2021 23:07 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-049477 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 13:11 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048398 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417 Underlying: Ordinary Shares · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.